- Home
- ENLV vs TRIB Comparison
ENLV vs TRIB Comparison
Compare ENLV & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENLV
- TRIB
- Stock Information
- Founded
- ENLV 2005
- TRIB 1992
- Country
- ENLV Israel
- TRIB Ireland
- Employees
- ENLV N/A
- TRIB N/A
- Industry
- ENLV Biotechnology: Pharmaceutical Preparations
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ENLV Health Care
- TRIB Health Care
- Exchange
- ENLV Nasdaq
- TRIB Nasdaq
- Market Cap
- ENLV 20.7M
- TRIB 25.5M
- IPO Year
- ENLV 1995
- TRIB N/A
- Fundamental
- Price
- ENLV $1.01
- TRIB $0.59
- Analyst Decision
- ENLV Strong Buy
- TRIB
- Analyst Count
- ENLV 2
- TRIB 0
- Target Price
- ENLV $10.00
- TRIB N/A
- AVG Volume (30 Days)
- ENLV 146.1K
- TRIB 37.2K
- Earning Date
- ENLV 04-11-2025
- TRIB 05-22-2025
- Dividend Yield
- ENLV N/A
- TRIB N/A
- EPS Growth
- ENLV N/A
- TRIB N/A
- EPS
- ENLV N/A
- TRIB N/A
- Revenue
- ENLV N/A
- TRIB $59,126,000.00
- Revenue This Year
- ENLV N/A
- TRIB $11.63
- Revenue Next Year
- ENLV N/A
- TRIB $10.13
- P/E Ratio
- ENLV N/A
- TRIB N/A
- Revenue Growth
- ENLV N/A
- TRIB N/A
- 52 Week Low
- ENLV $0.81
- TRIB $0.56
- 52 Week High
- ENLV $4.59
- TRIB $3.55
- Technical
- Relative Strength Index (RSI)
- ENLV 44.89
- TRIB 36.73
- Support Level
- ENLV $0.92
- TRIB $0.56
- Resistance Level
- ENLV $1.13
- TRIB $0.71
- Average True Range (ATR)
- ENLV 0.10
- TRIB 0.04
- MACD
- ENLV -0.01
- TRIB -0.01
- Stochastic Oscillator
- ENLV 24.32
- TRIB 15.62
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.